Team 2021-06-18T10:44:54+10:00
KEITH DOBSONManaging Director
Keith is the founder and visionary of myliquitab and continues to be the driving force behind the commercialisation of the technology. Keith has a history in the healthcare area in Europe and Australia as a Senior Clinician and also was involved in running a large number of healthcare projects, facilities and technologies, nursing homes, hostels, retirement village communities and community organizations. Keith has also been involved in the commercialisation of a number of technologies.
DR DAVID A V MORTONAdvisor to the Board/Consultant
Dr David Morton is a globally-recognised expert in the applied science and technology underpinning product development of pharmaceutical inhalers and other solid-dose pharmaceutical products, with input into multiple products marketed globally, and associated technology licensing agreements in excess of Au$500M. Spanning diverse R&D powder technology and aerosol science roles in industry and academia, David has recently focused on building innovative and effective university-industry partnerships in advanced product industrialisation. David has authored over 35 patent applications, over 100 scientific publications/book chapters.
Wayne has worked in the investment & finance fields for over 25 years. He has been the chairman of 2 public companies, lectured on investment and finance, consulted on behalf of governments, and considered among the very best investment advisers in Australia by Personal Investor Magazine. Wayne has extensive experience in building companies from the ground up, with all of them very profitable and some being sold for extremely handsome rewards.
WALLY TENCHCorporate Communications
With a background in Product Design and Development, Wally has been involved the launch and communications of emerging technologies for over 25 years. He is experienced in the development of communications and delivery across all channels and in working with international and national based clients.
DAVID BOYCEDirector International Market Expansion
David Boyce is one of Asia’s leading Healthcare Industry experts, having developed a reputation for high performance delivery across the APAC Region. David has 18 years’ experience in Healthcare in medical, diagnostics, and pharmaceutical sectors, and have lived in 4 countries and managed business in 13 markets including China, Australia, Vietnam, Thailand, Korea, and other SE Asian markets. With core skills in Commercial Operations and Channel Management, David has a proven track record for assessing business strategies and matching them with market opportunities.
BRUCE WARLOWChief Financial Officer
The myLiquitab Chief Financial Officer is a financial professional having worked in the financial services sector for over 45 years. With qualifications in Accounting, Financial Planning, Aged Care Provision and Auditing, he joins to assist in the commercialisation of the myLiquitab technology.
Our pharmacist is a professional community pharmacist with over 10 years of experience on advising members of the public and other health professionals about both prescriptions and over the counter medications. Having graduated from Monash University and completing her Masters from the University of Melbourne, our pharmacists’ expertise include appropriate drug selection, dosage and drug interactions, potential side effects and how medications are to be taken or used in the safest and most effective way.
Ian comes from a engineering and mechanical background and has been involved in the design, building and implementation of machinery across sectors such as farming and agriculture, food processing, cold storage and packaging as well as construction. Ian and his wife Sue bring a very practical and hands on approach to myLiquitab’s warehousing, stock control and product dispatch management.